Company Financials

Arena Pharmaceuticals, Inc. Financials

Indonesian rupiah

business Arena Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: ARNA

Market Capitalization $6.17 Billion as of March 1, 2022

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 9.18
Forward PE 7.77
Price to Sales TTM Rp1.30
Price to Book MRQ Rp2.06
Enterprise to Revenue 1.26
Enterprise to EBITDA 5.43

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-06-30
Profit Margin 14.29%
Operating Margin 17.66%
Return on Assets TTM 13.30%
Return on Equity TTM 22.98%

Income Statement

Revenue TTM Rp2,884,228,087,808
Revenue per Share TTM Rp403.82
Quarterly Revenue Growth 7.10%
Gross Profit TTM Rp902,974,078,976
EBITDA Rp561,769,011,837
Net Income to Common TTM Rp412,245,164,032
Diluted EPS TTM Rp57.72
Quarterly Earnings Growth YoY -13.10%

Balance Sheet

Total Cash MRQ Rp236,302,958,592
Total Cash per Share MRQ Rp33.53
Total Debt MRQ Rp
Total Debt to Equity MRQ 4.95
Current Ratio MRQ 1.94
Book Value per Share MRQ Rp257.35

Cash Flow

Operating Cash Flow TTM Rp736,574,898,176
Levered Free Cash Flow TTM Rp243,282,804,736

ARNA Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 7,053,760,876
Float Shares 3,216,473,560
Avg 10 Volume 3,843,670
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 52.09%
% Held by Institutions 14.52%

Stock Price Summary

Beta 0.29
Fifty Two Week Low Rp510.00
Fifty Two Week High Rp695.00
Fifty Two Week Change -27.10%
Day 50 MA Rp540.40
Day 200 MA Rp578.95

Dividends and Splits

Forward Annual Dividend Rate Rp172.00
Forward Annual Dividend Yield 32.15%
Trailing Annual Dividend Rate Rp43.00
Trailing Annual Dividend Yield 8.04%
Payout Ratio 74.52%
Dividend Date
Ex Dividend Date 2025-04-17
Last Split Factor
Last Split Date 2013-07-08